ArticleRevista de la Facultad de Ciencias Medicas (Cordoba, Argentina)2025
[Incidence of COVID-19 in cancer patients from the HIGA Alende, Mar del Plata, Argentina, 2020-2021]
Article in Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: COVID-19 differentially affected individuals with chronic diseases such as cancer, with greater severity and mortality than the general population. Objetives: Estimate the incidence of infection, hospitalization and fatality due to COVID-19 in cancer patients diagnosed between January 1, 2018 and December 31, 2020, treated at a Hospital in the city of Mar del Plata and evaluate risk factors for infection. Methods: retrospective cohort study in cancer patients aged 15 years or older. Demographic variables, comorbidities, tumor characteristics, oncological treatments, infection, hospitalization and death due to COVID-19 were collected. Kaplan-Meier curves and a Cox regression model were fitted, the time until infection was the response variable. Results: 995 patients were included and 8.9% had COVID-19. 95.6% had solid tumors, 41.4% had severe forms of cancer, 1.7% had more than one malignant tumor and 10.9% had tumors with metastatic forms. Patients under 60 years of age, with hematological cancer and/or severe forms of cancer had significantly higher risk of COVID-19 infection. Discussion: The greater circulation and exposure in those under 60 years of age could explain the higher risk of infection, while the decrease in the immune status in the case of solid cancers with more severe stages or those of a hematological type could explain the higher risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.